logo
Select company
Select metric
-3481.1%EBIT Margin
VS
Market
3
Sector
11
Industry
21
History
-
$ 3.7Close
$ 0.88 - $ 4.74 52-Week Range
Ticker Information

Ticker

PYXS

Company Name

PYXIS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PYXIS ONCOLOGY INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PYXS - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -98.17M-3481.1%$ 2.82M
3/31/2025$ -97.4M0%$ 0
12/31/2024$ -79.5M-492.35%$ 16.15M
9/30/2024$ -57.36M-355.24%$ 16.15M
6/30/2024$ -59.2M-366.67%$ 16.15M
3/31/2024$ -57.8M-358%$ 16.15M
12/31/2023$ -73.79M0%$ 0
9/30/2023$ -94.29M0%$ 0
6/30/2023$ -98.92M0%$ 0
3/31/2023$ -108.58M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PYXIS ONCOLOGY INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, PYXIS ONCOLOGY INC's average EBIT % has been -1010.67%.
  • The median EBIT % for PYXIS ONCOLOGY INC during this period was -366.67%
  • PYXIS ONCOLOGY INC reached its highest EBIT % over the past 5 years at -355.24%.
  • The lowest EBIT % recorded by PYXIS ONCOLOGY INC in the same timeframe -3481.1%

PYXIS ONCOLOGY INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
NTRB : NUTRIBAND INC -397.54%ALGS : ALIGOS THERAPEUTICS INC -1936.36%STTK : SHATTUCK LABS INC -2052.52%ORMP : ORAMED PHARMACEUTICALS INC -1750.95%CAMP : CAMP4 THERAPEUTICS CORP -1722.08%ARMP : ARMATA PHARMACEUTICALS INC -287.4%DTIL : PRECISION BIOSCIENCES INC -6097.94%NRXS : NEURAXIS INC -220.34%CBUS : CIBUS INC -4975.71%ABVC : ABVC BIOPHARMA INC -715.36%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for PYXIS ONCOLOGY INC is calculated as follows: EBIT [ $ -12.83M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

PYXS - EBIT Margin, Last 5 years

-3481.1%

Minimum

Jun 30, 2025

-355.24%

Maximum

Sep 30, 2024

-1010.67%

Average

-366.67%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%